Trillium Medical Ventures is a business development consulting company that serves the pharma division of Japan Tobacco. We are a dedicated search function for the small molecule drug discovery organization. We are seeking targets, enabling drug discovery technology, and hit2lead small molecules for the following disease areas

cardiometabolic (T2D complications, heart failure, NASH/ASH and sarcopenia)
Autoimmune disease (MS, SLE, IBD)
CNS disease (Alzheimer's and schizophrenia)
Chronic kidney disease